Oracle Faces Potential Restructuring Amid Financial Strain

Oracle US68389X1054

Mounting pressure is building around software titan Oracle. The company's ambitious $300 billion partnership with OpenAI, once a bold strategic move, is now raising serious questions among investors about financial viability. A recent analyst report paints a concerning picture, suggesting that drastic measures—including significant layoffs and asset sales—may be necessary to address liquidity concerns.

Market uncertainty and reports of a potential funding shortfall have made investors skittish. Oracle's share price currently stands at 165.90 euros, reflecting a decline of nearly 15 percent over the past month. The equity now trades more than 40 percent below its 52-week high, underscoring the market's deepening skepticism toward the firm's aggressive expansion strategy.

Signs of strain are also evident in the credit markets. A key warning indicator, the cost of insuring against an Oracle default via Credit Default Swaps (CDS), has tripled in recent months of 2025. This surge suggests institutional lenders now perceive a substantially higher risk of a liquidity crisis or default compared to a year ago.

Analyst Report Highlights Drastic Cost-Cutting Measures

The catalyst for this financial scrutiny is a report from investment bank TD Cowen, which stirred market unease. According to their analysis, Oracle is considering severe cost-reduction initiatives to manage the exploding expenses associated with its artificial intelligence infrastructure build-out.

The most drastic measure under consideration is a workforce reduction targeting 20,000 to 30,000 employees. TD Cowen estimates this "radical cut" could unlock between $8 billion and $10 billion in cash flow to shore up the company's liquidity position.

The $300 Billion OpenAI Deal: A Burden on Resources?

At the heart of the financial challenge is the immense demand for computing power driven by the five-year, $300 billion agreement with OpenAI. TD Cowen analysts calculate that fulfilling this contract alone will require capital expenditures (Capex) of approximately $156 billion, partly to fund the acquisition of three million high-performance graphics chips.

To manage these colossal sums, Oracle's leadership is reportedly evaluating the sale of its health division, Cerner, which was acquired for $28.3 billion in June 2022. Furthermore, the report indicates that U.S. banks have grown hesitant to finance additional data center projects, forcing Oracle to seek lenders in Asia. The company is also shifting terms for clients, now frequently demanding a 40 percent upfront payment on new contracts.

Awaiting Official Clarity

Oracle has not publicly commented on the TD Cowen report. Definitive insight into the company's strategy and financial health is expected with the release of its next quarterly report, scheduled for early March. At that time, management will need to demonstrate how it plans to balance enormous investment commitments with sound fiscal management, all without jeopardizing the core stability of the enterprise.